Organization | Orebro University

Orebro University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Örebro Sweden (1963)

Organization Overview

First Clinical Trial

2001

NCT00806403

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Clinical Epidemiology and Biostatistics, School of medical Sciences, örebro University, Sweden | County Council of Orebro, | County Council of Orebro, University of Orebro, Sweden | Department of Anaesthesiology and Intensive Care, Örebro University Hospital | Department of Cardiology, Örebro Univerity Hospital, 701 85 Örebro, Sweden | Department of Cardiology, Orebro University Hospital, Sweden | Department of Cardiology, Respiratory medicine and Physiology, Örebro University Hospital | Dept. of Anesthesia and Intensive Care, Orebro University Hospital, Orebro, Sweden | Dept of Cardiothoracic Surgery and Anestesiology, University Hospital Orebro, Sweden | Dept. of Gynecological Surgery, Orebro University Hospital, Orebro, Sweden | Institute of Medical Sciences, Örebro University, 701 82, Örebro, Sweden | Örebro County Council | Örebro kommun | Örebro university | Örebro University | Ôrebro University Hospital | Orebro University Hospital, Orebro, Sweden | Orebro University Hospital, Sweden | Örebro University, Region Örebro County | Örebro University, Region Örebro Län | Örebro University, School of Medical Sciences, Sweden | Orebro University, Sweden | Örebro University, Sweden | Region Örebro County | Region Örebro County/Örebro University | Region Orebro lan | Region Örebro län | Region Örebro Län | Section for Hematology, Örebro University Hospital | Universitetssjukhuset Örebro | Universitetssjukhuset Örebro, ANIVA-kliniken | University Health Care Research Center, Faculty of Medicine and Health, Örebro University | University hospital in Örebro | University Hospital Orebro | University Hospital Orebro, Sweden | University of Orebro | UOS trattamenti integrati della carcinosi peritoneale avanzata -UOC Chirurgia del peritoneo e retroperitoneo - Fondazione Policlinico Universitario A. Gemelli IRCCS

Active Ingredients

Drugs in Phase 4 Trials (33)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

alfentanil (alfenta) (1 trial)

azithromycin (zithromax) (1 trial)

bacille calmette-guerin (1 trial)

bilberry (2 trials)

cefixime (suprax) (1 trial)

ceftriaxone (rocephin) (1 trial)

clonidine (catapres) (1 trial)

dapagliflozin (farxiga) (1 trial)

dexmedetomidine (precedex) (1 trial)

doxycycline (vibramycin) (1 trial)

epinephrine (levophed) (6 trials)

inactivated influenza vaccine (1 trial)

ketorolac (acuvail) (6 trials)

lidocaine (xylocaine) (1 trial)

lithium (lithonate) (1 trial)

methylnaltrexone (relistor) (2 trials)

metoclopramide (reglan) (1 trial)

metoprolol (lopressor) (1 trial)

morphine (5 trials)

naloxone (narcan) (1 trial)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

prasugrel (effient) (1 trial)

propofol (diprivan) (1 trial)

radiolabeled albumin technetium Tc-99m albumin colloid kit (Microlite) (1 trial)

remifentanil (ultiva) (4 trials)

reteplase (Retavase) (1 trial)

ropivacaine (naropin) (10 trials)

sevoflurane (ultane) (1 trial)

sodium chloride (10 trials)

ticagrelor (brilinta) (1 trial)

tick-borne encephalitis vaccine (TICOVAC) (1 trial)

venlafaxine (effexor) (1 trial)

Drugs in Phase 3 Trials (10)

bicalutamide (casodex) (1 trial)

cabazitaxel (jevtana kit) (1 trial)

dronedarone (multaq) (1 trial)

flecainide (tambocor) (1 trial)

lactobacillus reuteri (2 trials)

leuprolide (lupron) (1 trial)

l-glutamine (2 trials)

oxygen (3 trials)

(r)-propafenone (1 trial)

sotalol (betapace) (1 trial)

Drugs in Phase 2 Trials (10)

1-(nitrosooxy)propan-2-ol (1 trial)

ag011 (1 trial)

buprenorphine (1 trial)

eplerenone (inspra) (1 trial)

glimepiride (amaryl) (1 trial)

liraglutide (victoza) (1 trial)

onabotulinumtoxinA (Botox) (1 trial)

paclitaxel (taxol) (1 trial)

rituximab (rituxan) (3 trials)

sitagliptin (januvia) (1 trial)

Drugs in Phase 1 Trials (1)

wharton's jelly mesenchymal stem cells (1 trial)

Drugs in Other Trials (27)

beta-glucans (1 trial)

bifidobacterium lactis (1 trial)

collagen (1 trial)

eicosapentanoic acid (1 trial)

endoprotease (1 trial)

escitalopram (lexapro) (1 trial)

fava beans (1 trial)

fiber (1 trial)

gentamicin (garamycin) (1 trial)

glucose (1 trial)

gonadorelin (factrel) (1 trial)

human fecal microbiota (Reybota) (3 trials)

indomethacin (indocin) (1 trial)

insulin human (humulin) (1 trial)

insulin lispro (humalog) (1 trial)

Lactobacillus acidophilus (1 trial)

lactobacillus casei (2 trials)

magnesium citrate (1 trial)

maltodextrin (2 trials)

omega-3 fatty acids (Omacor) (1 trial)

pleurotus eryngii extract (1 trial)

rhamnogalacturonan (1 trial)

sodium butyrate (1 trial)

vitamin d3 (2 trials)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Abdominal Pain (Phase 3)

Ascites (Phase 2)

Breast Neoplasms (Phase 4)

Carpal Tunnel Syndrome (Phase 4)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Colonic Neoplasms (Phase 4)

Colorectal Neoplasms (Phase 3)

Compulsive Personality Disorder (Phase 1)

Constipation (Phase 3)

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Deglutition Disorders (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Diarrhea (Phase 3)

Disease (Phase 1)

Dyspepsia (Phase 3)

Encephalitis (Phase 4)

Encephalitis, Tick-Borne (Phase 4)

Esophageal Diseases (Phase 4)

Fibrosis (Phase 2)

Heart Failure (Phase 3)

Infarction (Phase 4)

Influenza, Human (Phase 4)

Ischemia (Phase 3)

Leiomyoma (Phase 4)

Liver Cirrhosis (Phase 2)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Mental Disorders (Phase 1)

Myalgia (Phase 2)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 3)

Myofascial Pain Syndromes (Phase 2)

Myofibroma (Phase 4)

Neoplasms (Phase 4)

Obsessive-Compulsive Disorder (Phase 1)

Opioid-Related Disorders (Phase 2)

Pain (Phase 3)

Pain, Postoperative (Phase 4)

Postoperative Complications (Phase 3)

Prostatic Neoplasms (Phase 3)

Psychotic Disorders (Phase 1)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Rectal Neoplasms (Phase 4)

Schizophrenia (Phase 1)

Schizophrenia Spectrum and Other Psychotic Disorders (Phase 1)

Ulcer (Phase 2)

Uterine Neoplasms (Phase 4)

Vascular Diseases (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 75
# of Trial APIs: 81